As global markets navigate a complex landscape marked by steady interest rates in the U.S., rising rates in Japan, and mixed economic data across Europe and China, investors are keenly assessing opportunities for value. In such an environment, identifying stocks that are trading below their intrinsic value can be particularly appealing, as these may offer potential for growth when market conditions stabilize.

Top 10 Undervalued Stocks Based On Cash Flows

Name	Current Price	Fair Value (Est)	Discount (Est)
TRIAL Holdings (TSE:141A)	¥2737.00	¥5438.18	49.7%
Nexam Chemical Holding (OM:NEXAM)	SEK3.13	SEK6.20	49.6%
Laopu Gold (SEHK:6181)	HK$458.40	HK$906.50	49.4%
HD-Hyundai Marine Engine (KOSE:A071970)	₩67600.00	₩134827.13	49.9%
EVE Energy (SZSE:300014)	CN¥66.66	CN¥132.33	49.6%
Eurotech (BIT:ETH)	€1.35	€2.68	49.6%
Enea (OM:ENEA)	SEK75.00	SEK149.98	50%
Com.Tel (BIT:CMTL)	€1.79	€3.56	49.7%
Cint Group (OM:CINT)	SEK5.72	SEK11.39	49.8%
B&S Group (ENXTAM:BSGR)	€5.85	€11.66	49.8%

Let's take a closer look at a couple of our picks from the screened companies.

Almoosa Health (SASE:4018)

Overview: Almoosa Health Company is a private healthcare provider in the Kingdom of Saudi Arabia, with a market cap of SAR5.41 billion.

Operations: The company generates revenue through its segments, with Rehabilitation contributing SAR197.58 million, Pharmaceuticals SAR321.94 million, and Medical Services SAR922.12 million.

Estimated Discount To Fair Value: 20.9%

Almoosa Health is trading at SAR121.9, below its estimated future cash flow value of SAR154.14, indicating it is undervalued by more than 20%. Despite a decline in net income to SAR23.51 million for Q1 2026 from the previous year's SAR67.22 million, earnings are forecast to grow significantly at 26.5% annually over the next three years, outpacing the SA market's growth rate. However, high debt levels and reduced dividends may pose challenges ahead.

Ubtech Robotics (SEHK:9880)

Overview: Ubtech Robotics Corp Ltd focuses on the research, design, development, production, commercialization, marketing, and sale of robotic products and services across China, Hong Kong, and internationally with a market cap of HK$54.38 billion.

Operations: The company generates revenue from its Industrial Automation & Controls segment, which amounts to CN¥2.00 billion.

Estimated Discount To Fair Value: 14.0%

Ubtech Robotics, trading at HK$108.3, is undervalued compared to its estimated future cash flow value of HK$125.95. The company reported a reduced net loss of CNY 703.19 million for 2025, down from CNY 1,123.59 million the previous year. Revenue is expected to grow significantly at 47.9% annually over the next three years, surpassing market averages and indicating potential for profitability despite low forecasted return on equity of 8.2%.

Kioxia Holdings (TSE:285A)

Overview: Kioxia Holdings Corporation is engaged in the manufacturing and sale of memory and solid-state drives (SSDs) both in Japan and internationally, with a market capitalization of ¥52.92 billion.

Operations: The company generates revenue primarily from its Memory Business, amounting to ¥2.34 billion.

Estimated Discount To Fair Value: 47%

Kioxia Holdings, trading at a significant discount to its estimated future cash flow value of ¥196,691.54, reported impressive earnings growth with net income rising to ¥554.49 billion for the year ended March 31, 2026. Despite high volatility in share price and a substantial debt load, Kioxia's revenue is forecasted to grow at 27.9% annually over the next three years, outpacing market averages and reflecting strong potential based on cash flows.

Turning Ideas Into Actions

• Click here to access our complete index of 397 Undervalued Global Stocks Based On Cash Flows.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.